Jefferson Shreve bought Vertex Pharmaceuticals Inc (NASDAQ: VRTX)
Jefferson Shreve (R-IN), a U.S. Representative, has disclosed 3 trades in Vertex Pharmaceuticals Inc (VRTX) since 2025, 2 purchases and 1 sale, worth an estimated $98K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Jefferson Shreve bought $15,001 - $50,000 of Vertex Pharmaceuticals Inc (NASDAQ: VRTX) on February 24, 2025. Since that trade, VRTX is up +0.01% against the S&P 500 up +26.00%, an outperformance of -25.99%.
Across these filings, Jefferson Shreve has been a net buyer of VRTX (a buy-to-sell ratio of 2.00). The most recent disclosed VRTX transaction shown was dated May 12, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Jefferson Shreve's VRTX trades vs the price
VRTX is up +0.01% since Jefferson Shreve bought on February 24, 2025, versus +26.00% for the S&P 500.
Performance since this trade
All Jefferson Shreve VRTX trades
Jefferson Shreve & VRTX trading FAQ
Is it legal for Jefferson Shreve to trade Vertex Pharmaceuticals Inc (VRTX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Vertex Pharmaceuticals Inc (VRTX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Jefferson Shreve buy VRTX?
Jefferson Shreve disclosed a purchase of $15,001 - $50,000 of Vertex Pharmaceuticals Inc (VRTX) on February 24, 2025, according to public STOCK Act filings.
How has VRTX performed since Jefferson Shreve's trade?
Since Jefferson Shreve bought VRTX on February 24, 2025, the stock is up +0.01%, versus +26.00% for the S&P 500 over the same period, an outperformance of -25.99%.
How many times has Jefferson Shreve traded VRTX?
Jefferson Shreve has disclosed 3 VRTX trades since 2025 (2 purchases and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional VRTX trades?
Quantellect tracks every disclosed congressional trade in Vertex Pharmaceuticals Inc (VRTX) on the Vertex Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Jefferson Shreve's VRTX tradesAll congressional filings for Vertex Pharmaceuticals IncJefferson Shreve's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.